Salivary caffeine in Parkinson’s disease
Abstract We aimed to investigate salivary caffeine content, caffeine absorption and metabolism in Parkinson’s disease (PD) and verify whether salivary caffeine can be used as a biomarker of PD. We enrolled 98 PD patients and 92 healthy subjects. Caffeine and its major metabolite, paraxanthine, were...
Guardado en:
Autores principales: | Giorgio Leodori, Maria Ilenia De Bartolo, Daniele Belvisi, Alessia Ciogli, Andrea Fabbrini, Matteo Costanzo, Simone Manetto, Antonella Conte, Claudio Villani, Giovanni Fabbrini, Alfredo Berardelli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a18969ffd7364c09aa30c41879aa4f47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi D, et al.
Publicado: (2018) -
Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease
por: Berardelli I, et al.
Publicado: (2018) -
Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson's disease
por: Andrea Guerra, et al.
Publicado: (2022) -
Kinematic and diffusion tensor imaging definition of familial Marcus Gunn jaw-winking synkinesis.
por: Antonella Conte, et al.
Publicado: (2012) -
Inferior parietal lobule encodes visual temporal resolution processes contributing to the critical flicker frequency threshold in humans.
por: Andrea Nardella, et al.
Publicado: (2014)